Medicine and Dentistry
Neoplasm
100%
Pleura Mesothelioma
99%
Biological Marker
91%
Video-Assisted Thoracoscopic Surgery
66%
Overall Survival
65%
C Reactive Protein
53%
Lung
46%
Non Small Cell Lung Cancer
44%
Surgery
42%
Immunity
39%
Platelet
37%
Lung Cancer
37%
Lymph Duct
33%
Programmed Death-Ligand 1
33%
Transcatheter Aortic Valve Replacement
33%
Vascular Bundle
33%
Malignant Pleural Effusion
33%
Meta-Analysis
33%
Lobectomy
33%
Tumor Cell
33%
Thorax Surgery
33%
Ponatinib
33%
Solitary Fibrous Tumor
33%
Visceral Pleura
33%
Trabectedin
33%
Pleural Tumor
33%
Phrenic Nerve
33%
Chemotherapy
33%
Retrospective Study
33%
Estrone
33%
Analgesia
33%
Neurinoma
33%
Regional Anesthesia
33%
Opiate
33%
Calreticulin
33%
Lymphocyte
33%
Care Pathway
33%
Postoperative Pain
26%
Immune Checkpoint Inhibitor
24%
Prosthesis
19%
COVID-19
16%
STAT6 Protein
16%
Fibrofolliculoma
16%
Radiation Therapy
16%
Multivariate Analysis
16%
Neutrophil
13%
Drug Therapy
13%
Visual Analog Scale
13%
Translating (Language)
13%
Prognostic Factor
11%
Lymph Node
11%
Diseases
10%
Kirsten Murine Sarcoma Virus
8%
Clinical Trial
8%
Systemic Therapy
8%
Epidermal Growth Factor Receptor
8%
Connective Tissue Cancer
8%
Targeted Therapy
8%
Drug Repositioning
8%
Programmed Death 1 Ligand 1
8%
Oncology
6%
Epidural Analgesia
6%
Piritramide
6%
Metamizole
6%
Enhanced Recovery After Surgery
6%
Proportional Hazards Model
6%
Leukocyte
6%
Low Platelet Count
6%
Pleurectomy
6%
Decortication
6%
Neurogenic Tumor
6%
Perioperative Period
6%
Checklist
6%
Aortic Stenosis
6%
Percutaneous Aortic Valve Replacement
6%
Observational Study
6%
Randomized Clinical Trial
6%
Valve Prosthesis
6%
Heart Muscle Conduction Disturbance
6%
Open Heart Surgery
6%
Nonsteroid Antiinflammatory Agent
6%
Carbon Monoxide
6%
Quality of Life
6%
Postoperative Complication
6%
Systematic Review
6%
Pneumonectomy
6%
Prospective Study
5%
Adjuvant Therapy
5%
Adenocarcinoma
5%
Cell Dedifferentiation
5%
Phlebotomy
5%
Survival Rate
5%
Malignant Neoplasm
5%
Squamous Cell Carcinoma
5%
Recurrent Disease
5%
Pharmacology, Toxicology and Pharmaceutical Science
Pleura Mesothelioma
33%
Overall Survival
33%
Retrospective Study
33%
Trabectedin
33%
Ponatinib
33%
Apelin
33%
Aortic Stenosis
33%
Solitary Fibrous Tumor
33%
Biomarker Study
33%
Heart Muscle Conduction Disturbance
33%
Calreticulin
33%
Neoplasm
33%
Chemotherapy
33%
Non Small Cell Lung Cancer
33%
Immune Checkpoint Inhibitor
24%
Biological Marker
16%
STAT6 Protein
13%
Myelofibrosis
11%
Thrombocytosis
11%
Polycythemia vera
11%
Kirsten Murine Sarcoma Virus
8%
Programmed Death 1 Ligand 1
8%
Epidermal Growth Factor Receptor
8%
Clinical Trial
8%
Inflammation
8%
Piritramide
6%
Connective Tissue Cancer
6%
Drug Repositioning
6%